Exercise of Options, PDMR Dealing and Total Voting Rights

20 February 2019

Instem plc
("Instem")

Exercise of Options, PDMR Dealing and Total Voting Rights

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that it was notified on 19 February 2019 that certain Directors and employees of the Company, exercised share options (“Share Options”) over 235,339 ordinary shares of 10 pence each in the Company (“Ordinary Shares”).

Subsequently, on 19 February 2019, certain Directors sold some of the Ordinary Shares issued on the exercise of the options to finance the associated tax liabilities and for tax planning purposes.

Details of the Directors who participated in the exercise of Share Options and subsequent sale of Ordinary Shares are as follows:

Name of Director Number of Share Options exercised Number of Ordinary Shares sold Aggregate exercise price per Ordinary Share Resultant interest in Ordinary Shares Resultant interest in Ordinary Shares (%)
Phil Reason 93,750 73,750 10p 685,287 4.2%
Nigel Goldsmith 40,000 40,000 221.5p Nil Nil

Further details are set out below.

Application will be made to the London Stock Exchange for the admission of the 235,339 new Ordinary Shares to trading on AIM (“New Ordinary Shares”). Admission is expected to take place at 8.00 a.m. on 26 February 2019.  

Total voting rights
 
Following the issue and allotment of the above New Ordinary Shares, the Company's issued share capital comprises 16,153,270 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of voting rights in the Company is 16,153,270.

The figure of 16,153,270 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
Phil Reason, CEO of Instem commented:
 
"As the Company's CEO, a major long-term shareholder and substantial holder of options over additional Ordinary Shares, I am pleased to be increasing my shareholding through the exercise of these options."

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Phil Reason
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Instem plc
b) LEI 213800PILYUFNNROQX68
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB00B3TQCK30
b) Nature of the transaction Exercise of Options
c) Price(s) and volume(s) Price
10p (exercise price)
Volume(s)
93,750
d) Aggregated information
- Aggregated volume
- Price
N/A
N/A
e) Date of the transaction 19 February 2019
f) Place of the transaction London Stock Exchange (XLON)

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Phil Reason
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Instem plc
b) LEI 213800PILYUFNNROQX68
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB00B3TQCK30
b) Nature of the transaction Exercise of Options
c) Price(s) and volume(s) Price(s)
295p
Volume(s)
73,750
d) Aggregated information
- Aggregated volume
- Price
73,750
£217,562.50
e) Date of the transaction 19 February 2019
f) Place of the transaction London Stock Exchange (XLON)

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Nigel Goldsmith
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Instem plc
b) LEI 213800PILYUFNNROQX68
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB00B3TQCK30
b) Nature of the transaction Exercise of Options
c) Price(s) and volume(s) Price(s)
295p
Volume(s)
40,000
d) Aggregated information
- Aggregated volume
- Price

40,000
£118,000
e) Date of the transaction 19 February 2019
f) Place of the transaction London Stock Exchange (XLON)

For further information, please contact:

Instem plc www.instem.com
Phil Reason, CEO +44 (0) 1785 825600
Nigel Goldsmith, CFO  
N+1 Singer (Nominated Adviser & Broker) +44 (0) 207 496 3000
Richard Lindley  
Rachel Hayes  
Wallbrook Financial PR Tel: +44 (0) 207 933 8780
Paul Cornelius or instem@walbrookpr.com
Sam Allen  
Nick Rome  

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
 
Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.
 
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
 
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit instem.com.